Skip to main content
Caplight Logo









RoosterBio

RoosterBio

Private
Frederick, MarylandHealthcare & Life Scienceshttps://www.roosterbio.com/

Last Round

VC Round

Jul 25, 2024

Total Funding Raised

$23.85M

Company Overview

RoosterBio is a biotechnology company that provides human mesenchymal stem/stromal cells (hMSCs), bioprocess media, and manufacturing technologies for the cell therapy industry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Pharma Supply Chain

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

hMSCsmesenchymal stem cellsbioprocess mediaregenerative medicinecell therapyexosomescell manufacturingstem cell suppliercGMP manufacturinggene therapyprocess development servicesextracellular vesiclestissue engineeringcell bankinganalytical servicesFDA Master Files

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RoosterBio Comparables

Compare RoosterBio with similar companies based on industry and business-model similarity.

RoosterBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cellcolabs
79%
Celprogen
77%
OrganaBio
77%

RoosterBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 25, 2024
VC RoundMar 22, 2024
GrantMay 9, 2023
GrantMay 16, 2022
Series BSep 10, 2019
Grant
Jun 13, 2019

Key People

Founding team and executive leadership

Jon Rowley

Founder & Chief Product Officer

Founding Team

Chien-Chien Jacques

Chief Financial Officer

Executive Team

RoosterBio Investors

Notable investors and investment history

RoosterBio investors
InvestorRounds
Dynamk CapitalSeries B
Vanedge CapitalSeries B
Bioeconomy CapitalSeries B
Maryland Stem Cell Research FundGrant
BroadOak Capital PartnersVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 4, 2025

    Monthly visitors increased 42% MoM.

  • Jun 1, 2025

    Monthly visitors increased 53% MoM, from 4.5K to 6.9K.

RoosterBio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

RoosterBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about RoosterBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersFrederick, Maryland
Employee Range60
Year Founded2013
Last FundingJul 25, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?